Global HIV Treatment Market Report 2023: Enhanced Diagnostic Capabilities Fuels Growth
May 31, 2023 07:28 ET
|
Research and Markets
Dublin, May 31, 2023 (GLOBE NEWSWIRE) -- The "Global HIV Treatment Market: Analysis By Product, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2030" report has been added to ...
Trogarzoᴹᴰ (ibalizumab-uiyk) de Theratechnologies accélère l’atteinte d’une charge virale du VIH indétectable, prolonge son maintien et la suppression virale dans le cadre d’une étude de comparaison ajustée par appariement
May 04, 2023 07:30 ET
|
Theratechnologies
La première étude en son genre portant sur le traitement du VIH compare les résultats des essais cliniques sur l’ibalizumab aux données appariées provenant de la pratique réelle des patients n’ayant...
Theratechnologies’ Trogarzo® (Ibalizumab-uiyk) Shortens Time to HIV Undetectability and Extends Durability of Undetectability and Viral Suppression in a Matched Treatment Comparison
May 04, 2023 07:30 ET
|
Theratechnologies
First-of-its-Kind Study in HIV Compares Ibalizumab Clinical Trial Experience to Matched Real-World Non-Ibalizumab OPERA® CohortData Presented at ACTHIV™ Conference Highlight Improved Clinical Outcomes...
Vir Biotechnology Receives Expanded Support to Develop Its Novel T Cell Vaccine Platform with New $10 Million Grant for HIV Prevention
May 02, 2023 09:00 ET
|
Vir Biotechnology, Inc.
– New grant from the Bill & Melinda Gates Foundation supports the Phase 1 development of VIR-1388, an investigational HIV T cell vaccine based on a novel vector – – Long-standing partnership...
Alarming Rates of HIV and AIDS among Houston’s Blacks and Hispanics Bring National AIDS Memorial Quilt to the City
April 27, 2023 09:04 ET
|
National AIDS Memorial
HOUSTON, April 27, 2023 (GLOBE NEWSWIRE) -- The statistics tell the story, and there’s a serious HIV crisis in Houston and even more specifically among Blacks and Hispanics. That's why the National...
Uvax Bio Announces Publication of Results from Preclinical Studies of HIV Vaccine Candidates
April 26, 2023 07:30 ET
|
Uvax Bio
Uvax Bio-owned vaccines demonstrated significant improvement in immune response compared with current vaccine strategiesPhase 1 clinical trial sponsored by National Institutes of Health expected to...
bioLytical Laboratories Inc. Receives Health Canada Authorization for its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test
March 27, 2023 08:00 ET
|
bioLytical Laboratories Inc.
bioLytical has received Health Canada authorization to sell its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test across Canada for professional use in point-of-care settingsBy providing results for two...
HIV Drugs Market Size & Share to Surpass $40.3 Billion by 2030 | Vantage Market Research
March 24, 2023 06:58 ET
|
Vantage Market Research
WASHINGTON, March 24, 2023 (GLOBE NEWSWIRE) -- Global HIV Drugs Market is valued at USD 31.3 Billion in 2022 and is projected to reach a value of USD 40.3 Billion by 2030 at a CAGR (Compound Annual...
National AIDS Memorial Quilt Stops in Memphis to Break the Stigma and Change the Pattern Around AIDS in Black and Brown Communities
March 22, 2023 12:03 ET
|
National AIDS Memorial
MEMPHIS, Tenn., March 22, 2023 (GLOBE NEWSWIRE) -- Memphis ranks eighth in the nation for new HIV cases per year among large cities in the United States, according to the Infectious Disease Society...
Texas State Representative Launches Award-Winning Campaign to End HIV in Dallas County
March 21, 2023 11:08 ET
|
Southern Black Policy & Advocacy Network
Dallas, TX, March 21, 2023 (GLOBE NEWSWIRE) -- The Southern Black Policy and Advocacy Network (SBPAN), founded by Texas State Representative Venton Jones, won a MUSE Creative and Design Award for...